| - Industry | - Sector | Mr. Ravinder Sajwan CEO | SGX Exchange | - ISIN |
| Singapore Country | 101 Employees | - Last Dividend | - Last Split | - IPO Date |
UltraGreen.ai Limited is a dynamic company specializing in the manufacturing and sale of Indocyanine Green (ICG) pharmaceutical products. This company operates both within the United States and on an international scale. Beyond its pharmaceutical offerings, UltraGreen.ai Limited is at the forefront of diagnostic imaging analytics and innovative software solutions. The organization is particularly known for its advancements in software development that facilitate real-time blood perfusion quantification during surgical procedures. Notably, the company has developed the PerfusionWorks quantification software, which aids in tissue perfusion analysis, lymphatic mapping, and margin assessment. Established in 2024 and headquartered in Singapore, UltraGreen.ai Limited is a subsidiary of Renew Group Private Limited, reflecting a commitment to cutting-edge technologies in fluorescence-guided surgery.
ICG is a dye used primarily in medical imaging. It plays a crucial role in facilitating the visualization of blood flow and tissue perfusion, making it an essential component in various diagnostic and surgical procedures.
This advanced imaging system is designed for real-time assessment and visualization during surgical procedures. The IC-Flow Imaging System enhances the surgeon's ability to monitor blood flow and tissue viability, thereby improving surgical outcomes.
This comprehensive data platform supports healthcare providers in analyzing and interpreting diagnostic imaging data. The UltraGreen Data Platform integrates with existing healthcare systems to deliver accurate, real-time analytics for informed decision-making.
This specialized software provides real-time quantification of blood perfusion, which is vital during surgical procedures. It allows for precise lymphatic mapping and margin assessment, assisting in ensuring optimal surgical results and patient safety.
UltraGreen.ai Limited produces and sells ICG vials, designed for medical use. These products include various formulations of ICG and other related pharmaceutical offerings that support medical professionals in their diagnostic and therapeutic applications.
The company engages in continuous software development aimed at enhancing surgical outcomes and diagnostic capabilities. By focusing on innovative solutions and technologies, UltraGreen.ai Limited maintains its position at the cutting edge of the healthcare industry.